{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:34:07Z","timestamp":1794321247174,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL145228"],"award-info":[{"award-number":["HL145228"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-022-00551-7","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:05:08Z","timestamp":1648728308000},"page":"444-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-1145","authenticated-orcid":false,"given":"Patrick B.","family":"Ampomah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishuang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh R.","family":"Sukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan D.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Arif","family":"Yurdagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-914X","authenticated-orcid":false,"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lancia N. F.","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5747-3306","authenticated-orcid":false,"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sidoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-1762","authenticated-orcid":false,"given":"John M.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Tall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-1515","authenticated-orcid":false,"given":"Ira","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"551_CR1","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fimmu.2017.01400","volume":"8","author":"J Dalli","year":"2017","unstructured":"Dalli, J. & Serhan, C. N. Pro-resolving mediators in regulating and conferring macrophage function. Front. Immunol. 8, 1400 (2017).","journal-title":"Front. Immunol."},{"key":"551_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. Jr & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"551_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","volume":"50","author":"S Morioka","year":"2019","unstructured":"Morioka, S., Maueroder, C. & Ravichandran, K. S. Living on the edge: efferocytosis at the interface of homeostasis and pathology. Immunity 50, 1149\u20131162 (2019).","journal-title":"Immunity"},{"key":"551_CR4","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","volume":"80","author":"MF Linton","year":"2016","unstructured":"Linton, M. F. et al. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ. J. 80, 2259\u20132268 (2016).","journal-title":"Circ. J."},{"key":"551_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima, Y., Weissman, I. L. & Leeper, N. J. The role of efferocytosis in atherosclerosis. Circulation 135, 476\u2013489 (2017).","journal-title":"Circulation"},{"key":"551_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul, A. Jr et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 31, 518\u2013533 e510 (2020).","journal-title":"Cell Metab."},{"key":"551_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","volume":"29","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair. Cell Metab. 29, 443\u2013456 e445 (2019).","journal-title":"Cell Metab."},{"key":"551_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","volume":"31","author":"N A-Gonzalez","year":"2009","unstructured":"A-Gonzalez, N. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245\u2013258 (2009).","journal-title":"Immunity"},{"key":"551_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890\u2013898 (1998).","journal-title":"J. Clin. Invest."},{"key":"551_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00281-012-0342-8","volume":"35","author":"M Nakanishi","year":"2013","unstructured":"Nakanishi, M. & Rosenberg, D. W. Multifaceted roles of PGE2 in inflammation and cancer. Semin. Immunopathol. 35, 123\u2013137 (2013).","journal-title":"Semin. Immunopathol."},{"key":"551_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","volume":"50","author":"CD Funk","year":"2007","unstructured":"Funk, C. D. & FitzGerald, G. A. COX-2 inhibitors and cardiovascular risk. J. Cardiovasc. Pharmacol. 50, 470\u2013479 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"551_CR12","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.7150\/thno.63396","volume":"11","author":"H Cheng","year":"2021","unstructured":"Cheng, H., Huang, H., Guo, Z., Chang, Y. & Li, Z. Role of prostaglandin E2 in tissue repair and regeneration. Theranostics 11, 8836\u20138854 (2021).","journal-title":"Theranostics"},{"key":"551_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/FJC.0b013e3182244a12","volume":"59","author":"EH Tang","year":"2012","unstructured":"Tang, E. H., Libby, P., Vanhoutte, P. M. & Xu, A. Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J. Cardiovasc. Pharmacol. 59, 116\u2013123 (2012).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"551_CR14","doi-asserted-by":"publisher","first-page":"44147","DOI":"10.1074\/jbc.M204810200","volume":"277","author":"K Takayama","year":"2002","unstructured":"Takayama, K. et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277, 44147\u201344154 (2002).","journal-title":"J. Biol. Chem."},{"key":"551_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/cvr\/cvn286","volume":"81","author":"JM Gitlin","year":"2009","unstructured":"Gitlin, J. M. & Loftin, C. D. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice. Cardiovasc. Res. 81, 400\u2013407 (2009).","journal-title":"Cardiovasc. Res."},{"key":"551_CR16","doi-asserted-by":"publisher","first-page":"e98165","DOI":"10.1371\/journal.pone.0098165","volume":"9","author":"NS Kirkby","year":"2014","unstructured":"Kirkby, N. S. et al. COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks. PLoS ONE 9, e98165 (2014).","journal-title":"PLoS ONE"},{"key":"551_CR17","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1073\/pnas.1115313109","volume":"109","author":"Z Yu","year":"2012","unstructured":"Yu, Z. et al. Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. Proc. Natl Acad. Sci. USA 109, 6727\u20136732 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"551_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.prostaglandins.2007.03.004","volume":"84","author":"A Narasimha","year":"2007","unstructured":"Narasimha, A. et al. A novel anti-atherogenic role for COX-2\u2013potential mechanism for the cardiovascular side effects of COX-2 inhibitors. Prostaglandins Other Lipid Mediat. 84, 24\u201333 (2007).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"551_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/jb\/mvq043","volume":"147","author":"A Yoshimura","year":"2010","unstructured":"Yoshimura, A., Wakabayashi, Y. & Mori, T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J. Biochem. 147, 781\u2013792 (2010).","journal-title":"J. Biochem."},{"key":"551_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/hh2201.099415","volume":"89","author":"Z Mallat","year":"2001","unstructured":"Mallat, Z. et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930\u2013934 (2001).","journal-title":"Circ. Res."},{"key":"551_CR21","doi-asserted-by":"publisher","first-page":"17396","DOI":"10.1073\/pnas.1113421108","volume":"108","author":"J Martinez","year":"2011","unstructured":"Martinez, J. et al. Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc. Natl Acad. Sci. USA 108, 17396\u201317401 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"551_CR22","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1158\/1078-0432.CCR-14-0635","volume":"20","author":"Y Mao","year":"2014","unstructured":"Mao, Y. et al. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Clin. Cancer Res. 20, 4096\u20134106 (2014).","journal-title":"Clin. Cancer Res."},{"key":"551_CR23","first-page":"447","volume":"295","author":"WH Sun","year":"2000","unstructured":"Sun, W. H. et al. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J. Pharmacol. Exp. Ther. 295, 447\u2013452 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"551_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","volume":"12","author":"JM Mato","year":"2013","unstructured":"Mato, J. M., Martinez-Chantar, M. L. & Lu, S. C. S-adenosylmethionine metabolism and liver disease. Ann. Hepatol. 12, 183\u2013189 (2013).","journal-title":"Ann. Hepatol."},{"key":"551_CR25","doi-asserted-by":"publisher","first-page":"e13034","DOI":"10.1111\/acel.13034","volume":"18","author":"AA Parkhitko","year":"2019","unstructured":"Parkhitko, A. A., Jouandin, P., Mohr, S. E. & Perrimon, N. Methionine metabolism and methyltransferases in the regulation of aging and lifespan extension across species. Aging Cell 18, e13034 (2019).","journal-title":"Aging Cell"},{"key":"551_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nchembio.2384","volume":"13","author":"CL Quinlan","year":"2017","unstructured":"Quinlan, C. L. et al. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A. Nat. Chem. Biol. 13, 785\u2013792 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"551_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/s-2000-8466","volume":"26","author":"JD Finkelstein","year":"2000","unstructured":"Finkelstein, J. D. Pathways and regulation of homocysteine metabolism in mammals. Semin. Thromb. Hemost. 26, 219\u2013225 (2000).","journal-title":"Semin. Thromb. Hemost."},{"key":"551_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247\u2013257 (1999).","journal-title":"Cell"},{"key":"551_CR29","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1074\/jbc.M412722200","volume":"280","author":"KN Cho","year":"2005","unstructured":"Cho, K. N. et al. Prostaglandin E2 induces MUC8 gene expression via a mechanism involving ERK MAPK\/RSK1\/cAMP response element binding protein activation in human airway epithelial cells. J. Biol. Chem. 280, 6676\u20136681 (2005).","journal-title":"J. Biol. Chem."},{"key":"551_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.69","volume":"6","author":"Q Xia","year":"2015","unstructured":"Xia, Q. et al. Induction of COX-2-PGE2 synthesis by activation of the MAPK\/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia. Cell Death Dis. 6, e1702 (2015).","journal-title":"Cell Death Dis."},{"key":"551_CR31","doi-asserted-by":"publisher","first-page":"e72772","DOI":"10.1371\/journal.pone.0072772","volume":"8","author":"W Xiong","year":"2013","unstructured":"Xiong, W., Frasch, S. C., Thomas, S. M., Bratton, D. L. & Henson, P. M. Induction of TGF-beta1 synthesis by macrophages in response to apoptotic cells requires activation of the scavenger receptor CD36. PLoS ONE 8, e72772 (2013).","journal-title":"PLoS ONE"},{"key":"551_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","volume":"31","author":"B Cai","year":"2020","unstructured":"Cai, B. et al. Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis. Cell Metab. 31, 406\u2013421 e407 (2020).","journal-title":"Cell Metab."},{"key":"551_CR33","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 33, 2445\u20132463 e2448 (2021).","journal-title":"Cell Metab."},{"key":"551_CR34","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.1074\/jbc.RA118.006628","volume":"294","author":"C Nishi","year":"2019","unstructured":"Nishi, C., Yanagihashi, Y., Segawa, K. & Nagata, S. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation. J. Biol. Chem. 294, 7221\u20137230 (2019).","journal-title":"J. Biol. Chem."},{"key":"551_CR35","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.4049\/jimmunol.177.11.7497","volume":"177","author":"R Lang","year":"2006","unstructured":"Lang, R., Hammer, M. & Mages, J. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. 177, 7497\u20137504 (2006).","journal-title":"J. Immunol."},{"key":"551_CR36","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.celrep.2017.08.098","volume":"20","author":"J Newson","year":"2017","unstructured":"Newson, J. et al. Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1\/mPGES-1-derived prostaglandin E2. Cell Rep. 20, 3162\u20133175 (2017).","journal-title":"Cell Rep."},{"key":"551_CR37","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.1524292113","volume":"113","author":"B Cai","year":"2016","unstructured":"Cai, B. et al. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc. Natl Acad. Sci. USA 113, 6526\u20136531 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"551_CR38","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.154.5.2366","volume":"154","author":"Y Ren","year":"1995","unstructured":"Ren, Y. & Savill, J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J. Immunol. 154, 2366\u20132374 (1995).","journal-title":"J. Immunol."},{"key":"551_CR39","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1093\/eurheartj\/ehs228","volume":"34","author":"K Tse","year":"2013","unstructured":"Tse, K. & Ley, K. Transforming growth factor-beta: transforming plaque to stability. Eur. Heart J. 34, 3684\u20133686 (2013).","journal-title":"Eur. Heart J."},{"key":"551_CR40","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/eji.201141792","volume":"41","author":"O Takeuch","year":"2011","unstructured":"Takeuch, O. & Akira, S. Epigenetic control of macrophage polarization. Eur. J. Immunol. 41, 2490\u20132493 (2011).","journal-title":"Eur. J. Immunol."},{"key":"551_CR41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","volume":"31","author":"DG Roy","year":"2020","unstructured":"Roy, D. G. et al. Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming. Cell Metab. 31, 250\u2013266.e259 (2020).","journal-title":"Cell Metab."},{"key":"551_CR42","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1021\/acsomega.8b03571","volume":"4","author":"J Ji","year":"2019","unstructured":"Ji, J. et al. Methionine attenuates lipopolysaccharide-induced inflammatory responses via DNA methylation in macrophages. ACS Omega 4, 2331\u20132336 (2019).","journal-title":"ACS Omega"},{"key":"551_CR43","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1128\/MCB.00840-08","volume":"29","author":"Y Shikauchi","year":"2009","unstructured":"Shikauchi, Y. et al. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol. Cell. Biol. 29, 1944\u20131958 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"551_CR44","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nature13899","volume":"517","author":"X Guo","year":"2015","unstructured":"Guo, X. et al. Structural insight into autoinhibition and histone H3-induced activation of DNMT3A. Nature 517, 640\u2013644 (2015).","journal-title":"Nature"},{"key":"551_CR45","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/s41467-018-04426-y","volume":"9","author":"Z Dai","year":"2018","unstructured":"Dai, Z., Mentch, S. J., Gao, X., Nichenametla, S. N. & Locasale, J. W. Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat. Commun. 9, 1955 (2018).","journal-title":"Nat. Commun."},{"key":"551_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12859","volume":"7","author":"G Fredman","year":"2016","unstructured":"Fredman, G. et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat. Commun. 7, 12859 (2016).","journal-title":"Nat. Commun."},{"key":"551_CR47","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.08-112201","volume":"22","author":"AJ Merched","year":"2008","unstructured":"Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N. & Chan, L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595\u20133606 (2008).","journal-title":"FASEB J."},{"key":"551_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.RES.0000204451.88147.96","volume":"98","author":"K Takayama","year":"2006","unstructured":"Takayama, K., Sukhova, G. K., Chin, M. T. & Libby, P. A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling. Circ. Res. 98, 499\u2013504 (2006).","journal-title":"Circ. Res."},{"key":"551_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal, S. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377, 111\u2013121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"551_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.119.316461","volume":"127","author":"M Sharma","year":"2020","unstructured":"Sharma, M. et al. Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression. Circ. Res. 127, 335\u2013353 (2020).","journal-title":"Circ. Res."},{"key":"551_CR51","doi-asserted-by":"publisher","first-page":"630170","DOI":"10.3389\/fimmu.2021.630170","volume":"12","author":"E Toussirot","year":"2021","unstructured":"Toussirot, E., Bonnefoy, F., Vauchy, C., Perruche, S. & Saas, P. Mini-Review: The administration of apoptotic cells for treating rheumatoid arthritis: current knowledge and clinical perspectives. Front. Immunol. 12, 630170 (2021).","journal-title":"Front. Immunol."},{"key":"551_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbmt.2013.10.010","volume":"20","author":"D Mevorach","year":"2014","unstructured":"Mevorach, D. et al. Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I\/IIa clinical trial. Biol. Blood Marrow Transpl. 20, 58\u201365 (2014).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"551_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ebiom.2019.06.016","volume":"45","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2. EBioMedicine 45, 341\u2013350 (2019).","journal-title":"EBioMedicine"},{"key":"551_CR54","doi-asserted-by":"publisher","first-page":"e63296","DOI":"10.1371\/journal.pone.0063296","volume":"8","author":"I Pujol-Autonell","year":"2013","unstructured":"Pujol-Autonell, I. et al. Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity. PLoS ONE 8, e63296 (2013).","journal-title":"PLoS ONE"},{"key":"551_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","volume":"532","author":"L Fourgeaud","year":"2016","unstructured":"Fourgeaud, L. et al. TAM receptors regulate multiple features of microglial physiology. Nature 532, 240\u2013244 (2016).","journal-title":"Nature"},{"key":"551_CR56","doi-asserted-by":"crossref","unstructured":"Kasikara, C. et al. Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis. J. Clin. Invest. e145275 (2021).","DOI":"10.1172\/JCI145275"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00551-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T23:59:38Z","timestamp":1675123178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1038\/s42255-022-00551-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741882620.793593498","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}